Board members at ILMN have been filing heavy sell orders. Keith Meister and Corvex Management unloaded a combined $293M in Illumina shares. The filings hit August 6 and August 21. Both sellers sit on the board as asset management representatives.
Medpace CEO August Troendle filed two separate sales. Together they total $27M. The MEDP founder sold at prices around $606–$619 per share. Three other Medpace insiders also sold in the same period — four sellers in all.
Energy Transfer founder Kelcy Warren went the other way. He filed a $13.8M purchase of ET shares on August 20. Warren bought 648,000 shares at $21.26. That kind of founder buying is a bullish signal from someone who knows the business best.
Charles Schwab himself filed two sales of SCHW stock worth $23M combined. Two other Schwab insiders also sold. The cluster of three sellers is worth watching.
JNJ CEO Joaquin Duato filed an $10.8M sale on August 7. Corpay CEO Ron Clarke filed a $20.8M sell on August 25.
On the buy side, Evolution AB's main shareholder filed a $569M purchase of EVO shares. That is one of the largest single insider buy filings seen recently.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
